v3.26.1
SCHEDULE OF REVENUE RECOGNITION (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Product Information [Line Items]        
Total net revenue $ 1,510,579 $ 1,269,483 $ 2,862,106 $ 3,123,080
Health Care, Patient Service [Member]        
Product Information [Line Items]        
Total net revenue [1] 1,244,142 942,067 2,326,352 2,512,449
Histology Service Fees [Member]        
Product Information [Line Items]        
Total net revenue 248,260 308,604 498,776 572,358
Medical Director Fees [Member]        
Product Information [Line Items]        
Total net revenue 17,544 17,309 35,005 33,897
Department of Defense Observational Studies [Member]        
Product Information [Line Items]        
Total net revenue 1,131
Other Revenues [Member]        
Product Information [Line Items]        
Total net revenue $ 633 $ 1,503 $ 842 $ 4,376
[1] Patient services fees include direct billing for CyPath® Lung diagnostic test of approximately $835,000 and $323,000 for the six months ended June 30, 2026 and 2025, respectively, and $474,000 and $153,000 for the three months ended June 30, 2026 and 2025, respectively.